HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX)
CUSIP: 427746102
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 182,615,507
- Total 13F shares
- 131,463,843
- Share change
- +6,631,640
- Total reported value
- $272,131,676
- Put/Call ratio
- 1.7%
- Price per share
- $2.07
- Number of holders
- 170
- Value change
- +$12,999,478
- Number of buys
- 86
- Number of sells
- 49
Quarterly Holders Quick Answers
What is CUSIP 427746102?
CUSIP 427746102 identifies HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 427746102:
Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Rubric Capital Management LP |
13F
|
Company |
15%
|
26,713,503
|
$58,769,707 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4.7%
|
8,563,419
|
$18,839,522 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.5%
|
8,225,585
|
$18,096,287 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
4.3%
|
7,852,000
|
$17,274,400 | — | 31 Mar 2025 | |
| Velan Capital Investment Management LP |
13F
3/4/5
|
Company · Other* |
3.8%
|
6,986,744
|
$15,370,837 | — | 31 Mar 2025 | |
| PALISADE CAPITAL MANAGEMENT, LP |
13F
|
Company |
2.9%
|
5,286,931
|
$11,631,248 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.6%
|
4,775,877
|
$10,506,929 | — | 31 Mar 2025 | |
| Tejara Capital Ltd |
13F
|
Company |
2.5%
|
4,577,407
|
$10,070,295 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
3,253,904
|
$7,158,589 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
3,113,728
|
$6,852,175 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.6%
|
3,004,676
|
$6,611,000 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.6%
|
2,986,197
|
$6,569,633 | — | 31 Mar 2025 | |
| AIGH Capital Management LLC |
13F
|
Company |
1.5%
|
2,778,200
|
$6,112,040 | — | 31 Mar 2025 | |
| JW Asset Management, LLC |
13F
|
Company |
1.3%
|
2,337,743
|
$5,143,035 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.2%
|
2,274,500
|
$5,003,900 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
2,235,459
|
$4,918,010 | — | 31 Mar 2025 | |
| Congress Park Capital LLC |
13F
|
Company |
1.1%
|
2,035,617
|
$4,478,358 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
1,933,405
|
$4,253,492 | — | 31 Mar 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.96%
|
1,752,924
|
$3,856,433 | — | 31 Mar 2025 | |
| Orchard Capital Management, LLC |
13F
|
Company |
0.78%
|
1,431,758
|
$3,149,868 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.76%
|
1,395,285
|
$3,069,627 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.69%
|
1,254,696
|
$2,760,333 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.6%
|
1,089,449
|
$2,396,788 | — | 31 Mar 2025 | |
| Clearline Capital LP |
13F
|
Company |
0.58%
|
1,059,911
|
$2,331,804 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.58%
|
1,052,981
|
$2,316,558 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.56%
|
1,028,678
|
$2,263,091 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.55%
|
995,394
|
$2,189,867 | — | 31 Mar 2025 | |
| Barry D. Quart |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
1,142,796
mixed-class rows
|
$2,142,511 | — | 18 Jan 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.53%
|
968,041
|
$2,129,689 | — | 31 Mar 2025 | |
| Monaco Asset Management SAM |
13F
|
Company |
0.53%
|
960,000
|
$2,112,000 | — | 31 Mar 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.44%
|
796,100
|
$1,751,420 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
700,000
|
$1,540,000 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.38%
|
696,443
|
$1,532,175 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.37%
|
669,171
|
$1,472,176 | — | 31 Mar 2025 | |
| CM Management, LLC |
13F
|
Company |
0.33%
|
600,000
|
$1,320,000 | — | 31 Mar 2025 | |
| Kevin Kotler |
3/4/5
|
Director |
—
class O/S missing
|
577,879
|
$1,242,440 | — | 22 Feb 2023 | |
| Richmond Brothers, Inc. |
13F
|
Company |
0.3%
|
544,901
|
$1,198,781 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.27%
|
501,490
|
$1,103,278 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.27%
|
487,242
|
$1,071,932 | — | 31 Mar 2025 | |
| NEXPOINT ASSET MANAGEMENT, L.P. |
13F
|
Company |
0.26%
|
475,750
|
$1,046,650 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.22%
|
394,600
|
$868,120 | — | 31 Mar 2025 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.19%
|
349,000
|
$767,800 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
328,342
|
$722,353 | — | 31 Mar 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.18%
|
322,600
|
$709,720 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.17%
|
314,275
|
$691,405 | — | 31 Mar 2025 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.15%
|
280,000
|
$616,000 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.15%
|
273,945
|
$602,679 | — | 31 Mar 2025 | |
| Apeiron RIA LLC |
13F
|
Company |
0.14%
|
262,542
|
$577,592 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.13%
|
229,332
|
$504,530 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.11%
|
199,381
|
$438,638 | — | 31 Mar 2025 |
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q2 2025
As of 30 Jun 2025,
HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) was held by
170 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
131,463,843 shares.
The largest 10 holders included
Rubric Capital Management LP, BlackRock, Inc., VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Velan Capital Investment Management LP, PALISADE CAPITAL MANAGEMENT, LP, Tejara Capital Ltd, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and D. E. Shaw & Co., Inc..
This page lists
170
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
164
Q2 2025 holders
170
Holder diff
6
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.